BIT's 8th International Drug Discovery Science and Technology (IDDST), held in Beijing International Convention Center on October 23-26, achieved a consummation. The theme of this conference is "Supporting Systems for Major Innovative Drugs". Over 500 honored guests presented at the ceremony and gave brilliant speeches on invitation, among them are Mr. Liu Yanguo, Deputy Director, State Administration of Foreign Experts Affairs; Mrs. Peng Yu, Director-General of China Medicinal Biotech Association; Mr. Liu Hailin, Deputy Director-General of China Medicinal Biotech Association; Dr. Xiaodan Mei, the Executive Chair of IDDST-2009, President of BIT Life Sciences; Dr. Erwin Neher, Nobel Prize Laureate in Physiology or Medicine 1991, Max Planck Institute for Biophysical Chemistry, Germany; Dr. Christian Amatore, Director of the Research Unit “PASTEUR”, CNS Full Professor, CNRS, ENS and UPMC, France; Dr. Bertil Lindmark, Vice President and Head, Clinical Division, AstraZeneca KK, Japan; Dr. Steve Yang, Vice President and Head of R&D in Asia, Pfizer, USA; Dr. Andreas Tschirky, Leader of BioDuro, A PPD® Company, China. More than 800 world-renowned experts, professors, laboratory principals, project leaders and representatives of well-known enterprises attended the conference.
This annual congress comprised 10 Chapters and 73 sections following the ceremony, including “Basic Sciences and Technologies of Drug Discovery”; “Emerging New Technologies and Key Platform Infrastructure for New Drug Discovery”; “Advances in Anti-Major Disease Drug R & D”; “Smart Medicinal Chemistry toward NCEs”…etc. Meanwhile, A huge success has been achieved by BIT science in hosting IDDST annual congress in Beijing which also supported by AstraZeneca and BioDuro.
This annual conference, brought together nearly 800 specialists from 40 countries and areas, was devoted to the leading issues and popular topics and provide up-to-date information to all over the world. On the other hand, the meeting provided a brilliant information platform for domestic researchers to communicate with international experts and pushed forward the drug discovery development.
According to the investigation after the conference, most of our participants expressed that they would like to attend IDDST in the next year. Depending on the warmly support and good suggestions from all of the participants, we are quite confident in organizing IDDST-2011 which would be better and more successful than IDDST-2010. All of us are looking forward to meeting you again in 2011.
★ Conference Picture
Opening Ceremony
Opening Ceremony
Opening Ceremony
Mr. Liu Yanguo, Deputy Director, State Administration of Foreign Experts Affairs, China
Mrs. Peng Yu, Director-General of China Medicinal Biotech Association, China
Mr. Liu Hailin, Deputy Director-General of China Medicinal Biotech Association, China
Dr. Erwin Neher, Nobel Prize Laureate in Physiology or Medicine 1991, Max Planck Institute for Biophysical Chemistry, Germany
Dr. Christian Amatore, Director of the Research Unit "PASTEUR", CNS Full Professor, CNRS, ENS and UPMC, France
Dr. Bertil Lindmark, Vice President and Head, Clinical Division, AstraZeneca KK, Japan
Dr. Steve Yang, Vice President and Head of R&D in Asia, Pfizer, USA
Dr. Andreas Tschirky, Leader of BioDuro, A PPD@ Company, China
Dr. Ming-Qiang Zhang, VP and CTO, Roche R&D China, China
Dr. John C. Lin,
Executive Director, Research, Rinat, Pfizer Inc., USA
Dr. Alan J Lewis, President and CEO, Juvenile Diabetes Research Foundation, UK
Dr. Ronald P. Evens,
Clinical Professor, University of Florida, President & CEO, MAPS 4 Biotec, Inc., USA
Dr. Marcus Hompesch, President – CEO, Profil Institute for Clinical Research Inc., USA
Dr. Hinnerk Boriss,
CEO, Sovicell GmbH, Germany
Dr. Robert U. Simpson, President-Cardiavent Inc., Professor-Pharmacology, University of Michigan Medical School, USA
Dr. Brian L. Walton, Associate Director of Interventional Cardiology Research, Director, CVEIT, Texas Heart Institute at St. Luke's Episcopal Hospital, USA
Dr. John C Burnett Jr, Marriott Family Professor of Cardiovascular Research
Director, Cardiorenal Research Laboratory, Mayo Clinic, USA
Dr. Alexander Meyer auf der Heyde, Partner - Pharmaceuticals & Medical Products, Accenture (China) Co., Ltd. China
Dr. Kim Connelly Smith,
Professor of Pediatrics,
Director Children's Tuberculosis Clinics, University of Texas Houston Medical School, USA
Dr. Alex F. Chen, Director, VA Vascular Surgery Research, Vascular Medicine Institute, McGowan Institute of Regenerative Medicine, University of Pittsburgh School of Medicine, USA
Dr. Juan J. Canales, Head Investigator, Research Group in Biopsychology & Comparative Neuroscience, Cavanilles Institute, University of Valencia, Spain
Dr. Lara Stevanato,
Senior Investigator, ReNeuron Group plc, UK
Dr. Angelo Carpi, Professor, Department of Reproduction and Ageing, University Hospital, Italy
Dr.Igor Smirnov, President, Global Quantech, Inc., USA
Dr. A. Omri, Professor, Director of Drug and Vaccine delivery Systems Laboratory, Laurentian University, Canada
Dr. Haihong Ni, Director of Computational Science, Chemizon, Inc., China
Dr. Richard Wang, Director, Strategic Alliance Asia & Portfolio and Operation Management, Innovation Center China, AstraZeneca Global R&D, China
Dr. Jason C.G. Halford, Director of the Kissileff Human Ingestive Behaviour Laboratory, University of Liverpool, UK
Dr. David C. Hay, Principal Investigator, RCUK Fellow, MRC Centre for Regenerative Medicine, UK
Dr. Nagaraj Nagathihalli, Managing Editor, Nutrition Journal,
Vanderbilt University School of Medicine, USA
Dr. Elisabeth Perzborn,
Bayer Schering Pharma AG, Germany
Dr. James S. MacDonald,
DABT, Chrysalis Pharma Consulting, LLC, USA
Dr. Ljiljana Harding,
Pfizer Global Research and Development, UK
Dr. Olivier Wenker, Professor of Anesthesiology, Director of Technology Discovery, Division of Anesthesiology and Critical Care, MD Anderson Cancer Center, USA
Dr. Arlene Amor, Director, Caerus Consulting Pty. Ltd, Australia
Dr. David Lester, President, ITHW, Inc., USA
Dr.Xiaoyan Jiang, Senior Scientist, Terry Fox Laboratory, BC Cancer Research Centre, Canada
Dr. Paul B. Tchounwou, Associate Dean & Presidential Distinguished Professor, Director, NIH RCMI-Center for Environmental Health, Jackson State University, USA
Dr.Pierre Guertin, President and CEO, Nordic Life Science Pipeline; Professor, Laval University, Canada
Dr.Mirko Diksic, Professor and Director, Department of Neurology and Neurosurgery, McGill University, Canada
Dr.Robert Levy, Senior Partner, Okapi Consultants, LLC; Director of Clinical Development, Primus Pharmaceuticals, Inc., USA
Dr.Kun Liu, Principal Scientist, Wyeth Research, USA
Dr.Christian Neri, Research Director at INSERM; Professor, University of Montreal, France
Dr. Carl K. Edwards, Associate Professor, University of Colorado Denver; Sr. Executive Vice President, R&D, Western States Biopharmaceuticals, Inc., USA
Dr. Sheraz Gul, Vice President & Head of Biology, European ScreeningPort GmbH, Germany
Dr.Dalia Cohen, Chief Scientific Officer, Rosetta Genomics, USA
Dr.Cornelis Hop, Director, Genentech Inc.
Dr.Gennadi V. Glinsky, Senior Scientist, Ordway Research Institute, Albany Medical College, USA
Dr.Anuj Chauhan, Associate Professor, Director of the Graduate Program, Chemical Engineering, University of Florida, USA
Dr. Jinping Dong, Senior Research Associate, Characterization Facility, Institute of Technology, University of Minnesota, USA
Dr.Geert Verdonk, Senior Research Scientist Quality, QA Schering Plough Corporation, The Netherlands
Dr.Douglas Gladstone, Co-Director, Bone Marrow Transplant Unit, Stony Brook University, USA
Dr.Liqun Yang, Business Development Manager, Innovation China UK (ICUK), King's College London Business Ltd, King's College London, UK
Dr. Yuval Neria,
Director, Trauma and PTSD Program, NYSPI & Columbia University Department of Psychiatry, USA
Dr.Jingjing Ye, Manager and Statistician, Pfizer Global Research and Development, Pfizer Inc., USA
Dr.Rosemarie Lichtner, Principal Scientist, PMI Research & Development, Philip Morris Research Laboratories GmbH, Germany
Dr.Donna Seto-Young, Director of Endocrinology & Metabolism Laboratory, Associate Professor of Medicine, Albert Eintein College of Medicine, Beth Israel Medicine, USA
Dr. Larry Liu, Senior Director, Global Health Economics & Outcomes Research, Pfizer Primary Care BU, USA
Dr.Alessandra Pani, Professor, Department of Biomedical Science & Technology, University of Cagliari, Italy
Dr. Ning Li, Senior Principal Scientist, Pfizer Global Biologics, St. Louis Laboratory, USA
Dr. Ajit Dangi,
President & CEO, Danssen Consulting, Chairman - Fulford India Ltd. (Subsidiary of Schering Plough Corporation USA), India
Dr. Jean-Pierre, President, Crown BioScience, Inc. USA
Dr. Jing-Shan Hu, Director of Merck In-Licensing, China
Dr. Tina Huang, VP & Acting General Manager, Beijing Facility, Bridge Laboratories, China
Dr. Hanming Tu, Director, Clinical IT, Octagon Research Solutions, USA
Dr. Zimeng Yan, Sr. Scientist I, AstraZeneca, USA
Dr.Yongxin Han, Vice President of Chemistry, General Manager of China Operations, Chemizon, Inc., China
Dr.Huailing Zhong, Senior Research Scientist, Department of Biological Research, Lundbeck Research USA
Dr Kiran Marthak, Director , Veeda Clinical Research, India
★ Exhibition and Poster
IDDST Congress 2010 is your best chance to showcase to drug discovery professionals in China. Developed to offer comfort to delegates while maximizing exhibitor exposure, the coffee break, and poster sessions will all take place in the exhibition area promoting frequent repeated opportunities for delegates to visit the exhibits. IDDST 2010 will take place at Beijing International Convention Center. Oral Presentations will be held on the 3rd floor of the building, where is next to the exhibition area.
Find New Prospects in this Marketplace! Meet Face-to-Face with buyers across the entire life sciences R&D value chain who are seeking best-in-class of drug discovery and development technologies, include leading scientists, group leaders and executives.
Why Reserve Booth at IDDST-2010?
IDDST 2010 is one of the world leading international events dedicated to the innovative ways to accelerate the drug discovery process, expand the clinical pipelines of promising drugs and biologics and reduce attrition of compounds due to safety and efficacy issues.
★ Tech Tour
Tour in Beijing
Beijing is located in the north of China, where the climate is temperate and humid.It is home to the Peking Man, one of the earliest human species that existed some 500,000 years ago. Historic records and archeological findings prove that as a city, Beijing dates back to more than 3,000 years ago. As the capital city of the People's Republic of China, Beijing is the nation's political and cultural center and also a center for international contacts, where People of all China's 56 ethnic groups are found. More…
Tour in Xi' an
Xi'an, China's ancient capital with a history dating back more than 3,000 years has become a must-see location for many tourists visiting China. The mausoleum of Qin Shi Huang, the unifier of China and its first Emperor, is home to what has become known as "the Eighth Wonder of the World," the Terracotta Warriors. This tour is a great opportunity to learn and experience a great deal of the ancient history of China. More...
If you interested in this tour, please select the package A when you register online
Thank BioDuro for the generous sponsorship to IDDST-2010 Thank AstraZeneca for the generous sponsorship to IDDST-2010 First Round of Abstract Submission is Open Registration is Open Calling for New Media Partners Calling for Session Chairs and Speakers
.jpg)
.jpg)
Thank BioDuro for the generous sponsorship to IDDST-2010
